Q2 2026
Read transcript →Milestone Pharmaceuticals Inc. (MIST) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$0.69
+6.67%
Mkt Cap $86.05M
Q1 2026
Read transcript →NASDAQ·Healthcare·Biotechnology
$0.69
+6.67%
Mkt Cap $86.05M
Q2 2026
Read transcript →Q1 2026
Read transcript →